SGA
CRL icon

Strategic Global Advisors’s Charles River Laboratories CRL Stock Holding History

Strategic Global Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,441
Closed -$242K – 133
2015
Q2 		$242K Sell
3,441
-6,700
-66% -$496K 0.14% 123
2015
Q1 		$804K Sell
10,141
-14,593
-59% -$1.08M 0.59% 46
2014
Q4 		$1.57M Buy
+24,734
New +$1.55M 1.4% 8

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Strategic Global Advisors's CRL Position: Q3 2015 in Review

Strategic Global Advisors sold out of Charles River Laboratories (CRL) in Q3 2015, closing a stake of 3,441 shares — an estimated $242K sold.

Strategic Global Advisors first reported a position in CRL in Q4 2014 and held it in 3 quarters. The position peaked at $1.57M in Q4 2014. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • Strategic Global Advisors reported no remaining Charles River Laboratories position as of Q3 2015 after selling out during the quarter.
  • Strategic Global Advisors sold 3,441 Charles River Laboratories shares in Q3 2015, an estimated $242K.
  • Strategic Global Advisors first reported a position in Charles River Laboratories in Q4 2014 and held it in 3 quarters.
  • Strategic Global Advisors's Charles River Laboratories position peaked at $1.57M in Q4 2014.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on Strategic Global Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.